Norman D. Schwartz - 05 Sep 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Reporting relationship: Chairman & CEO, Director, 10%+ Owner
Issuer ticker: BIO
Reported as of: 05 Sep 2025
Net transaction value: -$451,417
SEC form: 4
Accepted by SEC: 09 Sep 2025, 16:19:59 UTC
Prior SEC filing: 03 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Norman Schwartz

Key filing fact

Norman D. Schwartz filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 09 Sep 2025.

Key facts

This page summarizes Norman D. Schwartz's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 09 Sep 2025, 16:19.

Change

Previous filing in this sequence was filed on 03 Sep 2025.
Current net transaction value: -$451,417.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000940805 Primary reporting owner

SCHWARTZ NORMAN D

Relationship: Chairman & CEO, Director, 10%+ Owner
Address: C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES
Signature: /s/ Norman Schwartz
Signature date: 09 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIO BIO.B transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +3,455
Change %: +0.78%
Price: $0.000000
Shares after: 444,962
Date: 06 Sep 2025
Ownership: Direct
Footnotes: F1

BIO BIO.B transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: $451,417
Shares: -1,528
Change %: -0.34%
Price: $295.43
Shares after: 443,434
Date: 06 Sep 2025
Ownership: Direct

BIO BIO.B holding

Bio-Rad B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 361,466
Date: 05 Sep 2025
Ownership: Direct

BIO BIO.B holding

Bio-Rad B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 13,006
Date: 05 Sep 2025
Ownership: By Spouse
Footnotes: F2

BIO BIO.B holding

Bio-Rad B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,060,054
Date: 05 Sep 2025
Ownership: By Blue Raven Partners, L.P.
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIO BIO.B transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +16,439
Change %
Price: $0.000000
Shares after: 16,439
Date: 05 Sep 2025
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 16,439
Exercise price: $0.000000
Footnotes: F4, F5

BIO BIO.B transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -3,455
Change %: -25%
Price: $0.000000
Shares after: 10,367
Date: 06 Sep 2025
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 3,455
Exercise price: $0.000000
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Shares of Class A common stock acquired on the vesting of restricted stock units.

Footnote F2

The reporting person disclaims beneficial ownership of these shares.

Footnote F3

The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

Footnote F5

The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.